Feras Darwish
El-Hajji graduated with a BSc. (1st Class) in Pharmacy from The Applied Science
Private University (ASU) in 2002. Following graduation, he worked as a
formulation pharmacist in the Research & Development Department at Hikma
Pharmaceuticals in Amman, during which he graduated with MSc. in Pharmaceutical
Sciences from University of Jordan in 2006. In 2007, Feras joined the PhD
programme at Queen’s University Belfast (QUB) in Northern Ireland in the UK. He
was awarded PhD degree in Clinical Pharmacy and Pharmacy Practice in 2011, to
return back to ASU as an Assistant Professor then Associate Professor in
Faculty of Pharmacy. Dr Darwish El-Hajji's research is centred on studying the
role of pharmacist in both hospital and community pharmacy settings, especially
the pharmacist’s participation in antimicrobial use and infection control,
antimicrobial stewardship programmes, and knowledge about probiotics. His
research also extends to study in vivo drug interactions and pre-clinical
studies on animals. At the same time, he supervised a number of postgraduate
pharmacy students. The research teams Feras works with are not limited to ASU
and other Jordanian universities researchers, but also include researchers from
QUB, Antrim Area Hospital in Northern Ireland, and University of Ulster. During
his work in the ASU, Dr Feras has been entitled as chairman on Clinical
Pharmacy & Therapeutics Department, and Pharmaceutical Sciences and
Pharmaceutics Department. He was a member in the Originators & Biosimilars
registration committee in the JFDA, before joining the Drug Pricing committee.
Moreover, he is active in scientific and voluntary work within Jordan Pharmaceutical
Society.